tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Haleon PLC Advances Share Buyback Program with New Share Purchase

Story Highlights
Haleon PLC Advances Share Buyback Program with New Share Purchase

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

An update from Haleon PLC ( (GB:HLN) ) is now available.

Haleon PLC has announced the purchase and cancellation of 1,517,728 ordinary shares as part of its ongoing share buyback program. This transaction is part of the second tranche of the program, reflecting the company’s commitment to optimizing its capital structure and potentially enhancing shareholder value. The company’s registered share capital now stands at 8,981,923,508 ordinary shares, with 8,978,043,303 shares carrying voting rights. This move may impact shareholders’ interests and align with regulatory requirements under the FCA’s Disclosure Guidance and Transparency Rules.

The most recent analyst rating on (GB:HLN) stock is a Hold with a £350.00 price target. To see the full list of analyst forecasts on Haleon PLC stock, see the GB:HLN Stock Forecast page.

Spark’s Take on GB:HLN Stock

According to Spark, TipRanks’ AI Analyst, GB:HLN is a Neutral.

Haleon PLC’s overall stock score is driven by strong financial performance and strategic corporate actions like share buybacks. However, technical analysis indicates bearish trends, and valuation metrics suggest moderate attractiveness. Earnings call insights reveal both opportunities and challenges, particularly in North America.

To see Spark’s full report on GB:HLN stock, click here.

More about Haleon PLC

Haleon PLC is a global leader in consumer health, focusing on delivering better everyday health with a human touch. The company offers a diverse range of products across six major categories, including Oral Health, Vitamins, Minerals and Supplements, Pain Relief, Respiratory Health, Digestive Health, and Therapeutic Skin Health. Its portfolio includes well-known brands such as Advil, Centrum, Otrivin, Panadol, parodontax, Polident, Sensodyne, Theraflu, and Voltaren, which are grounded in trusted science and innovation.

Average Trading Volume: 22,613,579

Technical Sentiment Signal: Sell

Current Market Cap: £31.41B

See more data about HLN stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1